The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats

被引:15
|
作者
Tanabe, Jun [1 ]
Ogura, Yuji [2 ]
Nakabayashi, Mikie [3 ]
Nagai, Yoshio [4 ]
Watanabe, Shiika [1 ]
Sugaya, Takeshi [1 ]
Ohata, Keiichi [1 ]
Ichikawa, Daisuke [1 ]
Inoue, Kazuho [5 ]
Hoshino, Seiko [5 ]
Kimura, Kenjiro [6 ]
Shibagaki, Yugo [1 ]
Ono, Yumie [3 ]
Kamijo-Ikemori, Atsuko [1 ,5 ]
机构
[1] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Physiol, Kawasaki, Kanagawa, Japan
[3] Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kawasaki, Kanagawa, Japan
[4] St Marianna Univ, Sch Med, Dept Internal Med, Div Metab & Endocrinol, Kawasaki, Kanagawa, Japan
[5] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan
[6] JCHO Tokyo Takanawa Hosp, Tokyo, Japan
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2019年 / 44卷 / 06期
基金
日本学术振兴会;
关键词
Diabetes; Diabetic kidney disease; Hypoxia; Kidney; Liver-type fatty acid-binding protein; Tubulointerstitial damage; TUBULOINTERSTITIAL INJURY; OXYGEN-CONSUMPTION; KIDNEY-DISEASE; RECEPTOR; HYPERGLYCEMIA; NEPHROPATHY; REFLECTS;
D O I
10.1159/000503926
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Renal hypoxia is an aggravating factor for tubulointerstitial damage, which is strongly associated with renal prognosis in diabetic kidney disease (DKD). Therefore, urinary markers that can detect renal hypoxia are useful for monitoring DKD. Objective: To determine the correlation between urinary liver-type fatty acid-binding protein (L-FABP) and renal hypoxia using a novel animal model of type 2 diabetes. Methods: Male spontaneously diabetic Torii (SDT) fatty rats (n = 6) were used as an animal model of type 2 diabetes. Age- and sex-matched Sprague-Dawley (SD) rats (n = 8) were used as controls. Body weight, systolic blood pressure, and blood glucose levels were measured at 8, 12, 16, and 24 weeks of age. Urine samples and serum and kidney tissues were collected at 24 weeks of age. Microvascular blood flow index (BFI) was measured using diffuse correlation spectroscopy before sampling both the serum and kidneys for the evaluation of renal microcirculation at the corticomedullary junction. Results: Obesity, hyperglycemia, and hypertension were observed in the SDT fatty rats. Focal glomerular sclerosis, moderate interstitial inflammation, and fibrosis were significantly more frequent in SDT fatty rats than in SD rats. While the frequency of peritubular endothelial cells and phosphoendothelial nitric oxide synthase levels were similar in both types of rats, the degree of renal hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression was significantly higher (and with no change in renal vascular endothelial growth factor expression levels) in the SDT fatty rats. Urinary L-FABP levels were significantly higher and renal microvascular BFI was significantly lower in the SDT fatty rats than in the SD rats. Urinary L-FABP levels exhibited a significant positive correlation with renal HIF-1 alpha expression and a significant negative correlation with renal microvascular BFI. Conclusions: Urinary L-FABP levels reflect the degree of renal hypoxia in DKD in a type 2 diabetic animal model. Urinary L-FABP may thus prove useful as a renal hypoxia marker for monitoring DKD in patients with type 2 diabetes in clinical practice.
引用
收藏
页码:1476 / 1492
页数:17
相关论文
共 50 条
  • [21] Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis
    Torigoe, Kenta
    Muta, Kumiko
    Tsuji, Kiyokazu
    Yamashita, Ayuko
    Ota, Yuki
    Kitamura, Mineaki
    Mukae, Hiroshi
    Nishino, Tomoya
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [22] Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease
    Atsuko Kamijo
    Takeshi Sugaya
    Akihisa Hikawa
    Masaya Yamanouchi
    Yasunobu Hirata
    Toshihiko Ishimitsu
    Atsushi Numabe
    Masao Takagi
    Hiroshi Hayakawa
    Fumiko Tabei
    Tokuichiro Sugimoto
    Naofumi Mise
    Masao Omata
    Kenjiro Kimura
    Molecular and Cellular Biochemistry, 2006, 284 : 175 - 182
  • [23] Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease
    Kamijo, Atsuko
    Sugaya, Takeshi
    Hikawa, Akihisa
    Yamanouchi, Masaya
    Hirata, Yasunobu
    Ishimitsu, Toshihiko
    Numabe, Atsushi
    Takagi, Masao
    Hayakawa, Hiroshi
    Tabei, Fumiko
    Sugimoto, Tokuichiro
    Mise, Naofumi
    Omata, Masao
    Kimura, Kenjiro
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 284 (1-2) : 175 - 182
  • [24] Clinical usefulness of urinary liver-type fatty acid-binding protein in congenital anomalies of the kidney and urinary tract
    Tanaka, Ryojiro
    Nakagawa, Taku
    Kanda, Kyoko
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1402 - 1402
  • [25] Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury
    Manabe, Kenichi
    Kamihata, Hiroshi
    Motohiro, Masayuki
    Senoo, Takeshi
    Yoshida, Susumu
    Iwasaka, Toshiji
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (05) : 557 - 563
  • [26] PROGNOSTIC VALUE OF URINARY CONCENTRATION OF LIVER-TYPE FATTY ACID-BINDING PROTEIN IN CHRONIC KIDNEY DISEASE
    Kanayama, Kyoko
    Hasegawa, Midori
    Kitagawa, Fumihiko
    Ishii, Jyunichi
    Yuzawa, Yukio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 109 - 110
  • [27] Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation
    Ichibayashi, Ryo
    Yamamoto, Saki
    Nakamichi, Yoshimi
    Masuyama, Yuka
    Serizawa, Hibiki
    Watanabe, Masayuki
    Yabe, Takayuki
    Honda, Mitsuru
    CLINICAL CASE REPORTS, 2022, 10 (11):
  • [28] Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria
    Nakamura, Tsukasa
    Sugaya, Takeshi
    Kawagoe, Yasuhiro
    Ueda, Yoshihiko
    Koide, Hikaru
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (05) : 385 - 389
  • [29] Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure
    Sunayama, Tsutomu
    Yatsu, Shoichiro
    Matsue, Yuya
    Dotare, Taishi
    Maeda, Daichi
    Ishiwata, Sayaki
    Nakamura, Yutaka
    Suda, Shoko
    Kato, Takao
    Hiki, Masaru
    Kasai, Takatoshi
    Minamino, Tohru
    ESC HEART FAILURE, 2022, 9 (01): : 442 - 449
  • [30] Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy
    Nakamura, T
    Sugaya, T
    Node, K
    Ueda, Y
    Koide, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (03) : 439 - 444